The number of pricing and coding changes to medically covered drugs is only increasing, and the ways to manage them are constantly evolving. We take a look at how claims reimbursement is currently being managed, as well as some best practices for leveraging specialty drug data to streamline the process.
Summary:
- Market fluctuations and evolving changes make management difficult
- Timeliness of updates is critical to ensure claims submission efficiency for appropriate reimbursement
- The number of NDCs to manage is growing — including high-volume weekly NDC mapping changes
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.